InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (2 ops.)
Browse the complete record of transactions filed by BARKER SAM L, Director. Insider active across 2 companies, notably Cyclacel Pharmaceuticals, Inc.. In total, 8 reports have been recorded. Total volume traded: €9k. The latest transaction was filed on 14 June 2022 — Attribution. Regulator: SEC (Form 4). The full history is free.
Declarations8 total
015,822 shares0
Common Stock
SEC:0001104659-22-071892:0·
04,024 shares0
Common Stock
SEC:0001127602-22-012825:0·
€3812 shares@ €3.16250.9% of flow
Common Stock
SEC:0001104659-21-145913·
€3812 shares@ €3.16250.4% of flow
Common Stock
SEC:0001104659-21-145913:0·
€4,2541,000 shares@ €4.254299.1% of flow
Common Stock
SEC:0001104659-21-109337·
Ideal exit: 21 May 2022 (T+270)
€4,2541,000 shares@ €4.254249.6% of flow
Common Stock
SEC:0001104659-21-109337:0·
Ideal exit: 21 May 2022 (T+270)
02,374 shares0
Common Stock
SEC:0001104659-21-082604·
02,374 shares0
Common Stock
SEC:0001104659-21-082604:0·
8 of 8 declarations
About BARKER SAM L
Sam L. Barker is a Board Member at Cyclacel Pharmaceuticals, Inc. and Lexicon Pharmaceuticals, Inc. He plays a key role in the governance of the companies, bringing his expertise in the pharmaceutical sector. His involvement on the boards is crucial for strategic development.
